MONEY LAUNDERING: COVID-19 TESTS

Our Taxes Benefit Everyone But Americans

Do you remember when Team Biden announced a new round of “FREE” COVID tests in September 2023?

As usual, it was just another ploy to give away American taxpayers money.

In the summer of 2023, most people thought COVID was a thing of the past and we wouldn’t hear about it again, but people like me know it’s never going away because it’s how you socially engineer fear and division.

On September 20, 2023, Team Biden reset America with COVID brain by announcing $600 Million being spent to “Bolster US Manufacturing of COVID-19 Tests”.

I knew this was a lie, almost everything from our government is a lie, so I dug in and peeled back layer after layer to find the top 6 companies awarded millions.

Check out the below image and let me know what you think!

FYI - I’m doing journalism different, just like T-Mobile did wireless different before they turned into the tyrannical Un-American company they are today. The above image can be downloaded and shared with friends in text messages.

Thanks - Marc Palasciano

---

HHS Press Release Below

September 20, 2023 - Biden-Harris Administration Awards $600 Million to Bolster US Manufacturing of COVID-19 Tests and Announces the Re-Opening of COVIDTests.gov

Today, the U.S. Department of Health and Human Services (HHS), through the Administration for Strategic Preparedness and Response (ASPR), is announcing an investment of $600 million across 12 domestic COVID-19 test manufacturers and the reopening of COVIDTests.gov to deliver COVID-19 tests for free to households across the country.

These critical investments in U.S. manufacturing will improve preparedness for COVID-19 and other pandemic threats of the future, strengthen the nation’s capacity to manufacture tests, and secure approximately 200 million new over-the-counter COVID-19 tests for future federal government use.

The awardees are:

• $88.7 million for Access Bio in New Jersey.

• $4.5 million for Advin in California.

• $61.2 million for Azure in Texas.

• $86.4 million for CorDx in California.

• $167 million for iHealth in California.

• $20.7 million for InBios in Washington.

• $31.4 million for Kwell Laboratories in California.

• $49.5 million for Maxim Bio in Maryland.

• $5.7 million for OraSure Technologies in Pennsylvania.

• $28.7 million for Princeton BioMeditech in New Jersey.

• $28.6 million for Quidel in California.

• $20.5 million for Sekisui in Delaware.